Ensuring the Appropriate Use of Glucagon‐Like Peptide‐1 Receptor Agonists
Kenneth Todd Moore is an employee and stockholder of Janssen Pharmaceuticals. Parag Kumar is an employee and stockholder of Gilead Sciences. Aman Gupta discloses no conflicts of interest. Jinshan Shen is an employee and stockholder of Relay Therapeutics. This will not be Open Access.
Authors
- Kenneth Todd Moore (ORCID: https://orcid.org/0000-0001-7505-102X)
- Aman Gupta (ORCID: https://orcid.org/0000-0001-7323-296X)
- Parag Kumar (ORCID: https://orcid.org/0000-0003-2757-8649)
- Jinshan Shen
Institutions
- George Washington University Virginia Campus (US)
Publication Details
- Journal
- The Journal of Clinical Pharmacology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1002/jcph.6136
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00